ODDO BHF Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Other funds holding DAWN
ODDO BHF Asset Management's DAWN Position: Q2 2026 in Review
ODDO BHF Asset Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,550,000 shares — an estimated $33.2M sold.
ODDO BHF Asset Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $33.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- ODDO BHF Asset Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- ODDO BHF Asset Management sold 1,550,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $33.2M.
- ODDO BHF Asset Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
- ODDO BHF Asset Management's Day One Biopharmaceuticals position peaked at $33.2M in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on ODDO BHF Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.